SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950116-02-000191
Filing Date
2002-02-08
Accepted
2002-02-08 00:00:00
Documents
1
Period of Report
2002-01-31

Document Format Files

Seq Description Document Type Size
1 4 four.txt 4 14250
  Complete submission text file 0000950116-02-000191.txt   16138
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 02531770
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEREX BIOTECHNOLOGY CORP 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CANADA M5J2G2
Business Address 33 HARBOUR SQUARE STE 202 TORONTO A6 M5H2G2 4163642551
GLUSKIN ANNA E (Reporting) CIK: 0001125857 (see all company filings)